event tracking

Research

510 results.

May 17, 2020 Releasing molecular ‘brake’ kick-starts immune cell function

GRAND RAPIDS, Mich. (May 18, 2020) — The immune system’s ability to marshal specialized cells to fight off infection relies in part on tiny molecules…

April 13, 2020 Being right-brained or left-brained comes down to molecular switches

GRAND RAPIDS, Mich. (April 14, 2020) — Scientists may have solved one of the most puzzling and persistent mysteries in neuroscience: why some people are…

February 12, 2020 $4.5 million co-funding agreement for Parkinson’s research announced

LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to announce a new three-year co-funding agreement that…

February 11, 2020 Van Andel Institute’s Juan Du, Ph.D. awarded Sloan Research Fellowship

GRAND RAPIDS, Mich. (Feb. 12, 2020) — The Alfred P. Sloan Foundation has named Van Andel Institute’s Juan Du, Ph.D., to its 2020…

February 3, 2020 World Cancer Day 2020: What energizes VAI scientists about the future of cancer research

February is National Cancer Prevention Month, and Feb. 4, 2020, is World Cancer Day.

To mark the occasion, Van Andel Institute scientists shared…

January 27, 2020 VAI Chief Investment Officer Kathleen Vogelsang named to AACSB’s 2020 Class of Influential Leaders

Grand Rapids, Mich. (Jan. 28, 2020) – Van Andel Institute Chief Investment Officer Kathleen Vogelsang has been named to the 2020 Class of Influential Leaders…

January 14, 2020 New study may lead to fewer hysterectomies in women with uterine fibroid tumors

Uterine fibroid tumors are the leading cause of hysterectomies in the U.S., yet little is known about what causes them. A new study, however, has…

January 12, 2020 Phase II clinical trial of respiratory drug for treatment of Parkinson's disease reveals promising results

The Cure Parkinson's Trust (CPT) is delighted to announce the publication of the results of a Phase II clinical trial evaluating ambroxol as a…